相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toll-Like Receptor 4 Is Involved in Human and Mouse Vein Graft Remodeling, and Local Gene Silencing Reduces Vein Graft Disease in Hypercholesterolemic APOE*3Leiden Mice
Jacco C. Karper et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction
Fatih Arslan et al.
CIRCULATION RESEARCH (2011)
Unexpected protective role for Toll-like receptor 3 in the arterial wall
Jennifer E. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Toll-like receptor 9-mediated pathway stimulates perilipin 3 (TIP47) expression and induces lipid accumulation in macrophages
Jian-Qiu Gu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists
Kenneth R. Feingold et al.
ATHEROSCLEROSIS (2010)
Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
Xinbing Han et al.
FASEB JOURNAL (2010)
Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis
QiQuan Huang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9
Dong Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9
Daqing Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
Hideyuki Yanai et al.
NATURE (2009)
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
Kim Midwood et al.
NATURE MEDICINE (2009)
A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation
Jin-Gu Lee et al.
CELLULAR SIGNALLING (2008)
Vessel-specific Toll-like receptor profiles in human medium and large arteries
Olga Pryshchep et al.
CIRCULATION (2008)
Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma
C. Erridge et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia
Wilbur H. Chen et al.
INNATE IMMUNITY (2008)
Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation
Shuang Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-α
Melissa B. Uccellini et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Arthur M. Krieg et al.
IMMUNOLOGICAL REVIEWS (2007)
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov et al.
BLOOD (2007)
HMGB1 modulates inflammatory responses in LPS-activated macrophages
M. El Gazzar
INFLAMMATION RESEARCH (2007)
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-α
Alexander Niessner et al.
CIRCULATION (2006)
Drug-eluting stents studies in mice: Do we need atherosclerosis to study restenosis?
Nuno M. M. Pires et al.
VASCULAR PHARMACOLOGY (2006)
Role of HMGB1 in cardiovascular diseases
W Li et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Tumor necrosis factor-α plays an important role in restenosis development
PS Monraats et al.
FASEB JOURNAL (2005)
Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3
M Martin et al.
NATURE IMMUNOLOGY (2005)
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development
AH Schoneveld et al.
CARDIOVASCULAR RESEARCH (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Toll-like receptor 4 is involved in outward arterial remodeling
SCG Hollestelle et al.
CIRCULATION (2004)
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions - Role of activated macrophages and cytokines
N Kalinina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes
MW Boulé et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions
A Vink et al.
CIRCULATION (2002)
Expression of toll-like receptors in human atherosclerotic lesions - A possible pathway for plaque activation
K Edfeldt et al.
CIRCULATION (2002)
分享论文
